ST. CHARLES SURGICAL HOSPITAL — History
CCN 190300 | 3-year financial timeline | COVID resilience: 29/100
🛡️ Public data only — no PHI permitted on this instance.
$30M
Latest Revenue (FY2022)
-3.1%
Revenue CAGR (3yr)
0.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $32M | $40M | $30M | -23.5% | -3.1% |
| Operating Expenses | $25M | $28M | $30M | +9.1% | +9.9% |
| Operating Margin | 22.4% | 30.1% | 0.3% | -99.1% | -89.0% |
| Net Income | $7M | $12M | $0M | -99.3% | -89.3% |
| Licensed Beds | 39 | 39 | 39 | +0.0% | +0.0% |
| Total Patient Days | 1,560 | 1,843 | 1,819 | -1.3% | +8.0% |
| Medicare Day % | 10% | 12% | 12% | +1.8% | +9.0% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 29/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -6.0% ($32M → $30M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-3.1%
This Hospital
+7.6%
State Avg
Latest Margin
0.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $29M | -10.8% |
| FY2024 (proj) | $28M | -21.8% |
| FY2025 (proj) | $27M | -32.9% |